CENPE and non-small cell lung carcinoma: This study aimed to investigate the potential of combining the BH3-mimetic navitoclax with the mitotic blocker CENPE inhibitor GSK923295 or the mitotic driver MPS1 inhibitor BAY1217389 in 2D and 3D in vitro models of NSCLC.